A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes

Author(s):
Buikhuisen, W.A. (0000-0002-0799-7187); Scharpfenecker, M.; Griffioen, A.W.; Korse, C.M.; Tinteren, H. van; Baas, P.
Published
2016
Publication type
Article / Letter to editor
MesotheliomaAxitinibVEGFAngiogenesisPhase IITranslational research
Date issued
2016-05-31
Language
English
Is part of
Journal of Thoracic Oncology (2016), Vol. 11, no. 5, p. 758-768
hdl
1887/113122
doi
10.1016/j.jtho.2016.01.014